These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 10216700
1. Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension. Patole S, Lee J, Whitehall J. Indian Pediatr; 1998 Dec; 35(12):1221-4. PubMed ID: 10216700 [No Abstract] [Full Text] [Related]
2. Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension. Patole S, Lee J, Whitehall J. Indian Pediatr; 1999 Mar; 36(3):307-10. PubMed ID: 10713845 [No Abstract] [Full Text] [Related]
3. Present and future of European neonatology: focus on patent ductus arteriosus. Fanos V, Guimarâes H. J Matern Fetal Neonatal Med; 2009 Mar; 22 Suppl 3():1-2. PubMed ID: 19925356 [No Abstract] [Full Text] [Related]
7. Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: a potential new drug for rescue therapy. Motti A, Tissot C, Rimensberger PC, Prina-Rousso A, Aggoun Y, Berner M, Beghetti M, da Cruz E. Pediatr Crit Care Med; 2006 Jul; 7(4):380-2. PubMed ID: 16738499 [Abstract] [Full Text] [Related]
8. Adenosine infusion for the management of persistent pulmonary hypertension of the newborn. Ng C, Franklin O, Vaidya M, Pierce C, Petros A. Pediatr Crit Care Med; 2004 Jan; 5(1):10-3. PubMed ID: 14697102 [Abstract] [Full Text] [Related]
11. Pharmacologic Treatment of Patent Ductus Arteriosus in the Preterm Infant. Gregory KE. J Perinat Neonatal Nurs; 2016 Jan; 30(1):6-8. PubMed ID: 26813387 [No Abstract] [Full Text] [Related]
12. [The pharmacological manipulation of Botallo's duct in the duct-dependent congenital cardiopathies and in the preterm infants with respiratory distress. A review and personal findings]. Distefano G. Minerva Pediatr; 2005 Feb; 57(1):21-34. PubMed ID: 15791199 [Abstract] [Full Text] [Related]
13. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Cherif A, Jabnoun S, Khrouf N. Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958 [Abstract] [Full Text] [Related]
14. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Sperandio M, Beedgen B, Feneberg R, Huppertz C, Brüssau J, Pöschl J, Linderkamp O. Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159 [Abstract] [Full Text] [Related]
16. Pharmacologic therapy for persistent pulmonary hypertension of the newborn: as "poly" as the disease itself. Oishi P, Fineman JR. Pediatr Crit Care Med; 2004 Jan; 5(1):94-6. PubMed ID: 14709984 [No Abstract] [Full Text] [Related]
17. [Drug therapy of persistent ductus arteriosus Botalli in the premature infant from the nursing viewpoint]. Busalt M. Kinderkrankenschwester; 2008 Sep; 27(9):361-7. PubMed ID: 18841637 [No Abstract] [Full Text] [Related]
18. Criteria for use of indomethacin injection in neonates. Renfro WH, Burr JM, Rawlings J. Clin Pharm; 1993 Mar; 12(3):232-4. PubMed ID: 8491081 [No Abstract] [Full Text] [Related]
19. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L. Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371 [Abstract] [Full Text] [Related]
20. Pharmacological closure of patent ductus arteriosus: effects on pulse pressure and on endothelin-1 and vasopressin excretion. Zanardo V, Vedovato S, Chiozza L, Faggian D, Favaro F, Trevisanuto D. Am J Perinatol; 2008 Jun; 25(6):353-8. PubMed ID: 18509786 [Abstract] [Full Text] [Related] Page: [Next] [New Search]